One Death Every Two Minutes from Cervical Cancer – and Vaccination Trends Moving in Wrong Direction 17/11/2021 Elaine Ruth Fletcher Some two-thirds of deaths of women from cervical cancer are happening in low- and middle-income countries that have not yet included human papillomavirus (HPV) vaccines for girls and young women into their immunization regimes, said WHO’s Director General Dr Tedros Adhanom Gheybresus on Wednesday. He was speaking at a high level event that saw First […] Continue reading -> White House to Invest Billions of Dollars in Expanding US Vaccine Manufacturing – for This Pandemic and Next 17/11/2021 Elaine Ruth Fletcher In a bid to better respond to both domestic and global needs, as well as future threats, the Biden Administration plans to spend billions of dollars to expand US vaccine manufacturing capacity enabling production of 1 billion vaccine doses a year by mid-2022, two top White House officials told US media on Wednesday. The announcement […] Continue reading -> Global Tobacco Use Declines, But Information About e-Cigarette Use is Lacking 16/11/2021 Raisa Santos The number of tobacco users globally has dropped from 1.32 billion in 2015 to 1.3 billion, and is expected to decline to 1.27 billion smokers by 2025, according to the fourth World Health Organization (WHO) global tobacco trends report. The report, released on Tuesday, revealed that 60 countries are now on track to achieving the […] Continue reading -> Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill 16/11/2021 Kerry Cullinan Pfizer has signed a voluntary license with the Medicines Patent Pool (MPP) to share the patents and knowledge to manufacture its new COVID-19 treatment drug, Paxlovid. According to the agreement, the MPP will be able to granting sub-licenses to qualified generic medicine manufacturers to supply the medicine in 95 countries, once regulatory authorization or approval […] Continue reading -> New Investment Funds of $75 Million Should Support More Tobacco Control Measures in Low- and Middle-Income Countries 15/11/2021 Elaine Ruth Fletcher While it pales in comparison to tobacco industry marketing, two new capital investment funds worth some $75 million to support low- and middle-income countries in their fight against tobacco are being created by signatories to the Framework Convention on Tobacco Control and a related Protocol on illegal sales. Together, the funds would yield an estimated […] Continue reading -> COP26 May Have Caused Despair, But Millions Caught in Climate Crises Face Serious Mental Health Challenges 15/11/2021 Kerry Cullinan While China and India’s last-minute refusal to commit to an end to fossil fuel at COP26 has caused depression and despair amongst many developing country delegates and climate activists, the mental health of millions is already severely affected by what climate disasters have done to their lives. Humidity and heatwaves are linked to increased suicides, […] Continue reading -> Humanitarian Groups Join Appeal to Make Health Central to Climate Debate – As Lukewarm COP26 Agreement Takes Final Shape 12/11/2021 Disha Shetty As the Glasgow Climate Conference winds to a close, the final COP26 declaration appears destined to contain watered-down language on fossil fuel phase-out, and no clear way forward for the $100 billion in finance needed by low-income countries. Against that landscape, Médecins Sans Frontières Dr Maria Guevara talks about why health is the elephant in […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
White House to Invest Billions of Dollars in Expanding US Vaccine Manufacturing – for This Pandemic and Next 17/11/2021 Elaine Ruth Fletcher In a bid to better respond to both domestic and global needs, as well as future threats, the Biden Administration plans to spend billions of dollars to expand US vaccine manufacturing capacity enabling production of 1 billion vaccine doses a year by mid-2022, two top White House officials told US media on Wednesday. The announcement […] Continue reading -> Global Tobacco Use Declines, But Information About e-Cigarette Use is Lacking 16/11/2021 Raisa Santos The number of tobacco users globally has dropped from 1.32 billion in 2015 to 1.3 billion, and is expected to decline to 1.27 billion smokers by 2025, according to the fourth World Health Organization (WHO) global tobacco trends report. The report, released on Tuesday, revealed that 60 countries are now on track to achieving the […] Continue reading -> Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill 16/11/2021 Kerry Cullinan Pfizer has signed a voluntary license with the Medicines Patent Pool (MPP) to share the patents and knowledge to manufacture its new COVID-19 treatment drug, Paxlovid. According to the agreement, the MPP will be able to granting sub-licenses to qualified generic medicine manufacturers to supply the medicine in 95 countries, once regulatory authorization or approval […] Continue reading -> New Investment Funds of $75 Million Should Support More Tobacco Control Measures in Low- and Middle-Income Countries 15/11/2021 Elaine Ruth Fletcher While it pales in comparison to tobacco industry marketing, two new capital investment funds worth some $75 million to support low- and middle-income countries in their fight against tobacco are being created by signatories to the Framework Convention on Tobacco Control and a related Protocol on illegal sales. Together, the funds would yield an estimated […] Continue reading -> COP26 May Have Caused Despair, But Millions Caught in Climate Crises Face Serious Mental Health Challenges 15/11/2021 Kerry Cullinan While China and India’s last-minute refusal to commit to an end to fossil fuel at COP26 has caused depression and despair amongst many developing country delegates and climate activists, the mental health of millions is already severely affected by what climate disasters have done to their lives. Humidity and heatwaves are linked to increased suicides, […] Continue reading -> Humanitarian Groups Join Appeal to Make Health Central to Climate Debate – As Lukewarm COP26 Agreement Takes Final Shape 12/11/2021 Disha Shetty As the Glasgow Climate Conference winds to a close, the final COP26 declaration appears destined to contain watered-down language on fossil fuel phase-out, and no clear way forward for the $100 billion in finance needed by low-income countries. Against that landscape, Médecins Sans Frontières Dr Maria Guevara talks about why health is the elephant in […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Tobacco Use Declines, But Information About e-Cigarette Use is Lacking 16/11/2021 Raisa Santos The number of tobacco users globally has dropped from 1.32 billion in 2015 to 1.3 billion, and is expected to decline to 1.27 billion smokers by 2025, according to the fourth World Health Organization (WHO) global tobacco trends report. The report, released on Tuesday, revealed that 60 countries are now on track to achieving the […] Continue reading -> Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill 16/11/2021 Kerry Cullinan Pfizer has signed a voluntary license with the Medicines Patent Pool (MPP) to share the patents and knowledge to manufacture its new COVID-19 treatment drug, Paxlovid. According to the agreement, the MPP will be able to granting sub-licenses to qualified generic medicine manufacturers to supply the medicine in 95 countries, once regulatory authorization or approval […] Continue reading -> New Investment Funds of $75 Million Should Support More Tobacco Control Measures in Low- and Middle-Income Countries 15/11/2021 Elaine Ruth Fletcher While it pales in comparison to tobacco industry marketing, two new capital investment funds worth some $75 million to support low- and middle-income countries in their fight against tobacco are being created by signatories to the Framework Convention on Tobacco Control and a related Protocol on illegal sales. Together, the funds would yield an estimated […] Continue reading -> COP26 May Have Caused Despair, But Millions Caught in Climate Crises Face Serious Mental Health Challenges 15/11/2021 Kerry Cullinan While China and India’s last-minute refusal to commit to an end to fossil fuel at COP26 has caused depression and despair amongst many developing country delegates and climate activists, the mental health of millions is already severely affected by what climate disasters have done to their lives. Humidity and heatwaves are linked to increased suicides, […] Continue reading -> Humanitarian Groups Join Appeal to Make Health Central to Climate Debate – As Lukewarm COP26 Agreement Takes Final Shape 12/11/2021 Disha Shetty As the Glasgow Climate Conference winds to a close, the final COP26 declaration appears destined to contain watered-down language on fossil fuel phase-out, and no clear way forward for the $100 billion in finance needed by low-income countries. Against that landscape, Médecins Sans Frontières Dr Maria Guevara talks about why health is the elephant in […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill 16/11/2021 Kerry Cullinan Pfizer has signed a voluntary license with the Medicines Patent Pool (MPP) to share the patents and knowledge to manufacture its new COVID-19 treatment drug, Paxlovid. According to the agreement, the MPP will be able to granting sub-licenses to qualified generic medicine manufacturers to supply the medicine in 95 countries, once regulatory authorization or approval […] Continue reading -> New Investment Funds of $75 Million Should Support More Tobacco Control Measures in Low- and Middle-Income Countries 15/11/2021 Elaine Ruth Fletcher While it pales in comparison to tobacco industry marketing, two new capital investment funds worth some $75 million to support low- and middle-income countries in their fight against tobacco are being created by signatories to the Framework Convention on Tobacco Control and a related Protocol on illegal sales. Together, the funds would yield an estimated […] Continue reading -> COP26 May Have Caused Despair, But Millions Caught in Climate Crises Face Serious Mental Health Challenges 15/11/2021 Kerry Cullinan While China and India’s last-minute refusal to commit to an end to fossil fuel at COP26 has caused depression and despair amongst many developing country delegates and climate activists, the mental health of millions is already severely affected by what climate disasters have done to their lives. Humidity and heatwaves are linked to increased suicides, […] Continue reading -> Humanitarian Groups Join Appeal to Make Health Central to Climate Debate – As Lukewarm COP26 Agreement Takes Final Shape 12/11/2021 Disha Shetty As the Glasgow Climate Conference winds to a close, the final COP26 declaration appears destined to contain watered-down language on fossil fuel phase-out, and no clear way forward for the $100 billion in finance needed by low-income countries. Against that landscape, Médecins Sans Frontières Dr Maria Guevara talks about why health is the elephant in […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Investment Funds of $75 Million Should Support More Tobacco Control Measures in Low- and Middle-Income Countries 15/11/2021 Elaine Ruth Fletcher While it pales in comparison to tobacco industry marketing, two new capital investment funds worth some $75 million to support low- and middle-income countries in their fight against tobacco are being created by signatories to the Framework Convention on Tobacco Control and a related Protocol on illegal sales. Together, the funds would yield an estimated […] Continue reading -> COP26 May Have Caused Despair, But Millions Caught in Climate Crises Face Serious Mental Health Challenges 15/11/2021 Kerry Cullinan While China and India’s last-minute refusal to commit to an end to fossil fuel at COP26 has caused depression and despair amongst many developing country delegates and climate activists, the mental health of millions is already severely affected by what climate disasters have done to their lives. Humidity and heatwaves are linked to increased suicides, […] Continue reading -> Humanitarian Groups Join Appeal to Make Health Central to Climate Debate – As Lukewarm COP26 Agreement Takes Final Shape 12/11/2021 Disha Shetty As the Glasgow Climate Conference winds to a close, the final COP26 declaration appears destined to contain watered-down language on fossil fuel phase-out, and no clear way forward for the $100 billion in finance needed by low-income countries. Against that landscape, Médecins Sans Frontières Dr Maria Guevara talks about why health is the elephant in […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COP26 May Have Caused Despair, But Millions Caught in Climate Crises Face Serious Mental Health Challenges 15/11/2021 Kerry Cullinan While China and India’s last-minute refusal to commit to an end to fossil fuel at COP26 has caused depression and despair amongst many developing country delegates and climate activists, the mental health of millions is already severely affected by what climate disasters have done to their lives. Humidity and heatwaves are linked to increased suicides, […] Continue reading -> Humanitarian Groups Join Appeal to Make Health Central to Climate Debate – As Lukewarm COP26 Agreement Takes Final Shape 12/11/2021 Disha Shetty As the Glasgow Climate Conference winds to a close, the final COP26 declaration appears destined to contain watered-down language on fossil fuel phase-out, and no clear way forward for the $100 billion in finance needed by low-income countries. Against that landscape, Médecins Sans Frontières Dr Maria Guevara talks about why health is the elephant in […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Humanitarian Groups Join Appeal to Make Health Central to Climate Debate – As Lukewarm COP26 Agreement Takes Final Shape 12/11/2021 Disha Shetty As the Glasgow Climate Conference winds to a close, the final COP26 declaration appears destined to contain watered-down language on fossil fuel phase-out, and no clear way forward for the $100 billion in finance needed by low-income countries. Against that landscape, Médecins Sans Frontières Dr Maria Guevara talks about why health is the elephant in […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Posts navigation Older postsNewer posts